via Wikipedia infobox
QazCovid-in, commercially known as QazVac, is a COVID-19 vaccine developed by the Research Institute for Biological Safety Problems in Kazakhstan. QazCoVac-P was the second COVID-19 vaccine developed by the Kazakh Biosafety Research Institute and in clinical trials.
== Manufacturing == The vaccine can be stored at standard refrigeration temperatures (2 °C-8 °C) and is a two-dose régime with the doses administered twenty-one days apart. The vaccine was first manufactured by Kazakhstan's Research Institute of Biological Safety Problems. Production capacity was capped at 50,000 doses per month.
via Wikidata sitelinks · CC0
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).